Evaluation of Offset of Conjunctival Hyperemia Induced by a Rho-Kinase Inhibitor; 0.4% Ripasudil Ophthalmic Solution Clinical Trial

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-40255-9

Related search